Purpose To identify the incidence of hospital-acquired venous thromboembolism (HAVTE),
evaluate the VTE risk factor screening, and evaluate the use and effectiveness of …

Abstract BACKGROUND: Hospital‐acquired (HA) venous thromboembolism (VTE) is a
common source of morbidity/mortality. Prophylactic measures are underutilized. Available …

Thromboprophylaxis for venous thromboembolism (VTE) failed to reduce overall mortality in
hospitalised medical patients. As a VTE prediction model for Asians is still lacking, this study …

Background: Venous thromboembolism (VTE) is a major healthcare problem that has
resulted in a significant increase in mortality, morbidity, and healthcare cost. Our knowledge …

Background: Without prophylaxis, hospital‐acquired deep vein thrombosis (DVT) is
approximately 10–40% among medical or general surgical patients and thromboprophylaxis …

Thromboprophylaxis remains often underused in hospitalized patients. In 2001, a cohort
study done at our institution, a tertiary care center in Montreal, Canada, showed that 67.7 …

Aim To investigate adherence to venous thromboembolism (VTE) prophylaxis guidelines in
patients who developed VTE within 90 days of hospital discharge. Method Inpatients …

Context: Guidelines to prevent venous thromboembolism (VTE) have been widely
distributed and generally have been assumed tobe effective. Therefore, among hospitalized …

Background Hospital‐acquired venous thromboembolism (VTE) is a major cause of
morbidity and mortality. Aims To determine the proportion of patients with hospital‐acquired …

Venous thromboembolism (VTE), ie, deep venous thrombosis (DVT) and pulmonary
embolism (PE), is the third most frequent cardiovascular disorder, and is associated with a …